维普中文期刊产品整合服务
22篇 您的检索式:作者名="Ching WM"
    题名 作者 年代 出处 被引量
1Expression and refolding of truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi and its use in enzyme-linked immunosorbent assays 显示文摘Ching WM Wang H Eamsila C 1998Clin Diagn Lab Immunol1998,5,4:1
2A case of accidental ingestion of ant bait containing fipronil显示文摘Fung HT Chan KK Ching WM Kam CW 2003J Toxicol Clin Toxicol2003,41,3:1
3Scrub typhus: the geographic distribution of phenotypio and genotypic variants of Orientia tsutsugamushi 显示文摘Kelly DJ Fuerst PA Ching WM 2009Clin Infect Dis2009,483,:1
4Scrub typhus: the geografic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi显示文摘Kelly DJ Fuerst PA Ching WM 2009Clin Infect Dis2009,48,:1
5Scrub typhus:the geographic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi显示文摘Kelly DJ Fuerst PA Ching WM 2009Clin Infec Dis2009,483,:1
6Characterization of the gene encoding the protective paracrystalline-surface-layer protein of Rickettsia prowazekii : presence of a mnicated identical homology in Rickettsia typhi显示文摘Carl M Dobson ME Ching WM 1990Proc Nail Acad Sci USA1990,87,21:1
7Mapping of monoclonal antibody binding sites on CNBr fragment of the S-layer protein antigens of Rickettsia typhi and Rickettsia prowazekii 显示文摘Ching WM Carl M Dasch GA 1992Mol Immunol1992,29,1:1
8DNA breakage bymethyl methanesulfonate and its repair in brain and liver cellscultured from fetal rat and mouse显示文摘Chen BP Berman JJ Ching WM 1983Chem Biol Interact1983,44,12:1
9Identification and characterization of epitopes on the 120-kilodalton surface protein antigen of Rickettsia prowazekii with synthetic peptides 显示文摘Ching WM Wang H Jan B 1996Infect Immun1996,64,4:1
10Scrub typhus: the geographic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi显示文摘Kelly DJ Fuerst PA Ching WM 2009Clin Infect Dis2009,48,3:1
11Recombinant major outer membrane protein antigen(r56) of Orientia tsutsugamushi and its use in enzyme-linked immunosorbent assays显示文摘Ching WM Wang H Eamsila C 1998Clin Diagn Lab Immunol1998,5,4:1
12Early diagnosis of scrub typhus with a rapid flow assay using recombinant major outer membrane protein antigen (r56) of Rickettsia tsutsugamushi显示文摘Ching WM Rowland D Zhang Z 2001Clin Diagn Lab Immunol2001,8,2:1
13Western blotting analysis of heat shock proteins of Rickettsiales and other eubaeteria显示文摘Eremeeva ME Ching WM Wu Y 1998FEMS Microbiol Lett1998,167,2:1
14Upfront consolidation treatment with 131I-mIBG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high-risk neuroblastoma显示文摘Importance:131I-metaiodobenzylguanidine(131I-mIBG)has a significant targeted antitumor effect for neuroblastoma.However,currently there is a paucity of data for the use of 131I-mIBG as a'front-line'therapeutic agent in those patients with newly diagnosed high-risk neuroblastoma as part of the conditioning regimen for myeloablative chemotherapy(MAC).Objective:To evaluate the feasibility of upfront consolidation treatment with 131I-mIBG plus MAC and hematopoietic stem cell transplantation(HSCT)in high-risk neuroblastoma patients.Methods:A retrospective,single-center study was conducted from 2003-2019 on newly diagnosed high-risk neuroblastoma patients without progressive disease(PD)after the completion of induction therapy.They received 131I-mIBG infusion and MAC followed by HSCT.Results:A total of 24 high-risk neuroblastoma patients were enrolled with a median age of 3.0 years at diagnosis.After receiving this sequential consolidation treatment,3 of 13 patients who were in partial response(PR)before 131I-mIBG treatment achieved either complete response(CR)(n=1)or very good partial response(VGPR)(n=2)after HSCT.With a median follow-up duration of 13.0 months after 131I-mIBG therapy,the 5-year event-free survival and overall survival rates estimated were 29%and 38%for the entire cohort,and 53%and 67%for the patients who were in CR/VGPR at the time of 131I-mIBG treatment.Interpretation:Upfront consolidation treatment with 131I-mIBG plus MAC and HSCT is feasible and tolerable in high-risk neuroblastoma patients,however the survival benefit of this 131I-mIBG regimen is only observed in the patients who were in CR/VGPR at the time of 131I-mIBG treatment.Jianhua Feng Frankie WT Cheng Alex WK Leung Vincent Lee Eva WM Yeung Hoi Ching Lam Jeanny Cheung Grace KS Lam Terry TW Chow Carol LS Yan Chi Kong Li 2020Pediatric Investigation2020,4,3:1
15Identification of a murine CD4+ T-lymphocyte response site in hepatitis C virus core protein显示文摘Chen ZP Berkower I Ching WM 1996Mol Immunol1996,33,78:1
16Recombinant major outer membrane protein antigen(r56) of Orientia tsutsugamushi and its use in enzyme-linked immunosorbent assays显示文摘 Wang H Eamsila C 1998Clin Diagn Lab Immunol1998,5,4:1
17Early diagnosis of scrub typhus with a rapid flow assay using recombinant major outer membrane protein antigen (r56) of Rickettsia tsutsugamushi 显示文摘 Rowland D Zhang Z 2001Clin Diagn Lab Immunol2001,8,2:1
18DNA breakage bymethyl methanesulfonate and its repair in brain and liver cellscultured from fetal rat and mouse显示文摘CHEN BP BERMAN JJ CHING WM 1983Chem Biol Interact1983,44,:1
19Extranodalmanifestation of Kimura's disease:ultrasound features显示文摘 Tsang WM Ahuja AT 2002Eur Radiol2002,12,2:1
20A case of accidental ingestion of ant bait containing fipronil显示文摘Fung HT Chan KK Ching WM 2003J Toxicol Clin Toxicol2003,1,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费